Clinical basics
Clinical nutrition: 4. Omega-3 fatty acids in cardiovascular care
Bruce J. Holub
CMAJ March 05, 2002 166 (5) 608-615;
Bruce J. Holub
Dr. Holub is Professor, Department of Human Biology and Nutritional Sciences, University of Guelph, Guelph, Ont.
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
Clinical nutrition: 4. Omega-3 fatty acids in cardiovascular care
Bruce J. Holub
CMAJ Mar 2002, 166 (5) 608-615;
Jump to section
- Article
- What are omega-3 fatty acids?
- Epidemiological evidence for the cardioprotective effects of EPA and DHA
- Possible biochemical and physiological mechanisms of action for EPA and DHA
- Intervention studies and risk factor modification using EPA and DHA
- What about ALA?
- Clinical trials with fish oil supplements and “hard” end points
- Target intakes of EPA and DHA for cardiovascular health
- Future perspectives in cardiovascular care
- Treatment for the patient
- Footnotes
- References
- Figures & Tables
- Responses
- Metrics
Related Articles
Cited By...
- (N-3) Fatty Acids: Molecular Role and Clinical Uses in Psychiatric Disorders
- Acute Fish Oil and Soy Isoflavone Supplementation Increase Postprandial Serum (n-3) Polyunsaturated Fatty Acids and Isoflavones but Do Not Affect Triacylglycerols or Biomarkers of Oxidative Stress in Overweight and Obese Hypertriglyceridemic Men
- Treating hypertriglyceridemia
- The Fish in Secondary Prevention of Heart Disease (FISH) Survey--Primary Care Physicians and {omega}3 Fatty Acid Prescribing Behaviors
- Practical Applications of Fish Oil ({Omega}-3 Fatty Acids) in Primary Care
- Dietary Flaxseed Protects against Ventricular Fibrillation Induced by Ischemia-Reperfusion in Normal and Hypercholesterolemic Rabbits
- Common problems in the management of hypertriglyceridemia
- Clinical nutrition: 7. Functional foods -- more than just nutrition